Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
Open Access
- 1 December 1993
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 52 (12), 876-880
- https://doi.org/10.1136/ard.52.12.876
Abstract
OBJECTIVE--To investigate whether soluble interleukin-2 receptor (sIL-2R) could be a useful marker of disease activity in rheumatoid arthritis (RA); sIL-2R levels in serum and in synovial fluid were determined by enzyme-linked immunosorbent assay. METHODS--Sixty five serum and 27 synovial fluid samples were obtained from patients with RA. Twenty five serum and 28 synovial fluid samples from patients with osteoarthritis (OA) were used as controls. Furthermore, 10 synovial fluid samples from healthy volunteers were also examined. Variable laboratory and clinical data were compared with serum sIL-2R levels, in 26 patients with RA and serial samples from some patients were examined. RESULTS--Concentrations of sIL-2R in serum (median 81, range 40-350 pM) and synovial fluid (median 125, range 52-460 pM) from patients with RA were significantly higher than in serum (median 45, range 13-100 pM) and synovial fluid (median 37, range 15-140 pM) from patients with OA, and healthy control synovial fluid (median 2.5, range 0-10 pM). Serum sIL-2R levels correlated strongly with serum levels of C-reactive protein (p = 0.0001), and a significant correlation with erythrocyte sedimentation rate (ESR) (p = 0.048), IgG levels (p = 0.028), IgA levels (p = 0.044) and Lansbury Index (p = 0.037) was observed. However, serum sIL-2R levels showed no significant correlation with rheumatic factor, IgM or T cell subsets. CONCLUSION--These findings indicate that sIL-2R levels in patients with RA reflect disease activity.Keywords
This publication has 29 references indexed in Scilit:
- Suppression of interleukin‐2 and interleukin‐2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cellsArthritis & Rheumatism, 1993
- Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiationArthritis & Rheumatism, 1992
- Elevated serum levels of soluble interleukin‐2 receptor in patients with Wegener's granulomatosis. Association with disease activityArthritis & Rheumatism, 1992
- Soluble interleukin 2 receptors in patients with polymyositis/dermatomyositis.Annals Of The Rheumatic Diseases, 1992
- Cellular source of soluble interleukin 2 receptors in serum of mice after recombinant interleukin 2 administrationCytokine, 1990
- Expression of Tac antigen on activated normal human B cells.The Journal of Experimental Medicine, 1984
- Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.The Journal of Immunology, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Preliminary criteria for clinical remission in rheumatoid arthritisArthritis & Rheumatism, 1981
- Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosusAmerican Journal Of Medicine, 1980